These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24620975)

  • 1. Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
    Wu X; Hanson LG; Skimminge A; Sorensen PS; Paulson OB; Mathiesen HK; Blinkenberg M
    Neurol Res; 2014 Aug; 36(8):701-8. PubMed ID: 24620975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study.
    Blinkenberg M; Mathiesen HK; Tscherning T; Jønsson A; Svarer C; Holm S; Sellebjerg F; Paulson OB; Hanson LG; Sorensen PS
    Neurol Res; 2012 Jan; 34(1):52-8. PubMed ID: 22196862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
    Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
    Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
    Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of erhuangfang for relapsing multiple sclerosis.
    Zhou L; Fan Y
    Neurol Res; 2015 Jul; 37(7):633-7. PubMed ID: 25668581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
    Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
    Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
    Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
    Kirov II; Tal A; Babb JS; Herbert J; Gonen O
    Neurology; 2013 Jan; 80(1):39-46. PubMed ID: 23175732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
    Jasperse B; Jakobs C; Eikelenboom MJ; Dijkstra CD; Uitdehaag BM; Barkhof F; Polman CH; Teunissen CE
    J Neurol; 2007 May; 254(5):631-7. PubMed ID: 17415509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
    Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N
    Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study.
    Calabrese M; Rinaldi F; Seppi D; Favaretto A; Squarcina L; Mattisi I; Perini P; Bertoldo A; Gallo P
    Radiology; 2011 Dec; 261(3):891-8. PubMed ID: 22031708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL
    NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
    Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
    Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
    Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.